Mupirocin Ointment, USP 2%, 22 grams tube, Rx only, MFG: Teva Pharma USA, NDC 0093-1010-42, MFG: Teva Pharma USA
Check against the official notice below — it lists the full affected range.
McKesson Medical-Surgical is recalling Mupirocin Ointment USP 2% in 22-gram tubes manufactured by Teva Pharma USA due to cGMP (current Good Manufacturing Practice) deviations involving temperature abuse. The affected product has the NDC number 0093-1010-42 and was distributed nationwide across the United States. A total of 5 tubes are involved in this recall.
McKesson is unable to identify the specific lot numbers received by individual customers, but the company has sent letters to affected consignees that include the distribution date and the date range during which the impacted product may have been shipped. The source document does not specify what action affected consumers should take in response to this recall.
Written by software from the official notice below. Not reviewed by a lawyer.
cGMP deviations: Temperature abuse
Reason for recall: cGMP deviations: Temperature abuse Distribution: USA nationwide. Quantity: 5 tubes Lot/code info: McKesson Medical-Surgical (MMS) is not able to identify the particular lot number received by a particular consignee for the recalled prescription products. Each letter includes the date it was distributed to customers and the dates that impacted product may have been shipped to the customer.
Official record: FDA (Drug enforcement) ↗
Republished from the official source above; details can change — the source record controls.